A Phase 1 Single and Multiple Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Baxdrostat in Healthy Japanese and Caucasian Subjects
Latest Information Update: 17 Aug 2023
At a glance
- Drugs Baxdrostat (Primary)
- Indications Hyperaldosteronism; Hypertension; Spinal cord disorders
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors AstraZeneca
Most Recent Events
- 27 Jul 2023 Status changed from recruiting to completed.
- 21 May 2019 New trial record